Medical Condition News

RSS

‘No one is ever really ready’: Aid-in-dying patient chooses his last day

In the end, it wasn't easy for Aaron McQ to decide when to die. The 50-year-old Seattle man — a former world traveler, triathlete and cyclist — learned he had leukemia five years ago, followed by an even grimmer diagnosis in 2016: a rare form of amyotrophic lateral sclerosis, or ALS.

14 Aug 2018

American College of Rheumatology receives grants to support development of lupus clinical trials

The American College of Rheumatology today announced the receipt of two, two-year grants from the Office of Minority Health to support the development of programs that aim to increase the recruitment and enrollment in lupus clinical trials of minority populations affected by lupus.

14 Aug 2018

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease in individuals who do not have asthma.

14 Aug 2018

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

More than two-thirds of women with ovarian cancer have high-grade serous carcinoma. Up to 90 percent of HGSCs are not detected until they are beyond the ovaries or fallopian tubes, at which point it may not be possible to fully remove the tumor.

14 Aug 2018

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia may produce long-term pain relief.

14 Aug 2018

New strategy accelerates, automates process of prototype molecule optimization

The search for new medicinal molecules with predetermined properties is a rather complex, expensive and time-consuming process, especially in oncology.

14 Aug 2018

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.

14 Aug 2018

Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells

More than 100 years ago, German Nobel laureate Paul Ehrlich popularized the "magic bullet" concept -- a method that clinicians might one day use to target invading microbes without harming other parts of the body. Although chemotherapies have been highly useful as targeted treatments for cancer, unwanted side effects still plague patients.

14 Aug 2018

Experts provide insight into novel concepts and approaches for stroke rehabilitation

Stroke remains a leading cause of adult disability, and the global burden of stroke continues to grow with devastating consequences for patients, families, and caregivers.

14 Aug 2018

New study focuses on promise of gene therapy for Amish nemaline myopathy

A new comprehensive natural history study about Amish nemaline myopathy in the Old Order Amish population focuses on the promise of gene therapy for this lethal disorder.

14 Aug 2018

Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes

Switching anti-psychotic medications does not improve clinical outcomes in patients with first-episode schizophrenia who haven't responded to treatment, Mount Sinai researchers have shown for the first time.

14 Aug 2018

University Hospitals Seidman Cancer Center launches new CAR-T therapy trial

University Hospitals Seidman Cancer Center launched a new clinical trial for CAR-T, joining a select group of hospitals offering the therapy and a smaller group of hospitals manufacturing the CAR-T cells.

14 Aug 2018

Rethinking fundamental rule of stroke care: 'Time is brain!'

In 1993, neurologist Camilo R. Gomez, MD, coined a phrase that for a quarter century has been a fundamental rule of stroke care: "Time is brain!"

14 Aug 2018

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.

14 Aug 2018

Google's DeepMind AI could soon be diagnosing eye conditions

London-based DeepMind which is owned by Google’s parent company Alphabet, is coming up with Artificial Intelligence based devices that can help diagnose eye conditions accurately.

14 Aug 2018

Study finds quality of doctor-patient discussions about lung cancer screening to be 'poor'

Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.

14 Aug 2018

AI platform identifies acute neurological illnesses faster than human diagnosis

An artificial intelligence platform designed to identify a broad range of acute neurological illnesses, such as stroke, hemorrhage, and hydrocephalus, was shown to identify disease in CT scans in 1.2 seconds, faster than human diagnosis, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the journal Nature Medicine.

14 Aug 2018

Medical Condition News

‘No one is ever really ready’: Aid-in-dying patient chooses his last day

American College of Rheumatology receives grants to support development of lupus clinical trials

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

New strategy accelerates, automates process of prototype molecule optimization

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells

Experts provide insight into novel concepts and approaches for stroke rehabilitation

New study focuses on promise of gene therapy for Amish nemaline myopathy

Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes

University Hospitals Seidman Cancer Center launches new CAR-T therapy trial

Rethinking fundamental rule of stroke care: 'Time is brain!'

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

Google's DeepMind AI could soon be diagnosing eye conditions

Study finds quality of doctor-patient discussions about lung cancer screening to be 'poor'

AI platform identifies acute neurological illnesses faster than human diagnosis

Simple score helps predict which hospitalized heart attack patients are at high risk of readmissions

Duke researchers track missing T-cells in glioblastoma patients

Study examines how a person adapts to visual field loss after stroke

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News